Back to top

CBD (CBD) Gains As Market Dips: What You Should Know

Read MoreHide Full Article

CBD (CBD - Free Report) closed at $22.58 in the latest trading session, marking a +0.36% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.63%. Meanwhile, the Dow lost 0.43%, and the Nasdaq, a tech-heavy index, lost 1.04%.

Prior to today's trading, shares of the retailer had gained 4.26% over the past month. This has outpaced the Retail-Wholesale sector's loss of 7.15% and the S&P 500's loss of 6.28% in that time.

Wall Street will be looking for positivity from CBD as it approaches its next earnings report date. This is expected to be November 8, 2018. In that report, analysts expect CBD to post earnings of $0.21 per share. This would mark year-over-year growth of 75%. Our most recent consensus estimate is calling for quarterly revenue of $3.09 billion, down 10.35% from the year-ago period.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $1 per share and revenue of $13.37 billion. These totals would mark changes of +117.39% and -4.38%, respectively, from last year.

Investors should also note any recent changes to analyst estimates for CBD. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. CBD currently has a Zacks Rank of #1 (Strong Buy).

Valuation is also important, so investors should note that CBD has a Forward P/E ratio of 22.5 right now. This represents a premium compared to its industry's average Forward P/E of 17.42.

Investors should also note that CBD has a PEG ratio of 1.11 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Retail - Supermarkets stocks are, on average, holding a PEG ratio of 2.27 based on yesterday's closing prices.

The Retail - Supermarkets industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 186, which puts it in the bottom 27% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Companhia Brasileira de Distribuicao (CBD) - free report >>

More from Zacks Tale of the Tape

You May Like

Published in